141 related articles for article (PubMed ID: 27457274)
1. Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity.
Deigin V; Ksenofontova O; Khrushchev A; Yatskin O; Goryacheva A; Ivanov V
ChemMedChem; 2016 Sep; 11(18):1974-7. PubMed ID: 27457274
[TBL] [Abstract][Full Text] [Related]
2. Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides.
Deigin V; Ksenofontova O; Yatskin O; Goryacheva A; Ignatova A; Feofanov A; Ivanov V
Int Immunopharmacol; 2020 Apr; 81():106185. PubMed ID: 32058926
[TBL] [Abstract][Full Text] [Related]
3. [Influence of peptide derivatives of diketopiperazines on hemopoietic stem cells of an intact organism and irradiated bone marrow cells in vitro].
Deĭgin VI; Saenko AS; Semin IuA; Shevchenko AS; Luzianina AA; Izmest'eva OS; Zhavoronkov LP
Radiats Biol Radioecol; 2011; 51(5):530-5. PubMed ID: 22279765
[TBL] [Abstract][Full Text] [Related]
4. Advancement from Small Peptide Pharmaceuticals to Orally Active Piperazine-2,5-dion-Based Cyclopeptides.
Deigin V; Linkova N; Volpina O
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686336
[TBL] [Abstract][Full Text] [Related]
5. 2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products.
Borthwick AD
Chem Rev; 2012 Jul; 112(7):3641-716. PubMed ID: 22575049
[No Abstract] [Full Text] [Related]
6. Cell-penetrating peptides containing 2,5-diketopiperazine (DKP) scaffolds as shuttles for anti-cancer drugs: conformational studies and biological activity.
Feni L; Jütten L; Parente S; Piarulli U; Neundorf I; Diaz D
Chem Commun (Camb); 2020 May; 56(42):5685-5688. PubMed ID: 32319458
[TBL] [Abstract][Full Text] [Related]
7. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
[TBL] [Abstract][Full Text] [Related]
8. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
Belkacem MA; Jannet HB; Ferhout H; Mzali L; Bouajila J
Med Chem; 2017; 13(8):744-752. PubMed ID: 28480832
[TBL] [Abstract][Full Text] [Related]
11. Influence of Open Chain and Cyclic Structure of Peptidomimetics on Antibacterial Activity in
Sahrawat P; Kowalczyk P; Koszelewski D; Szymczak M; Kramkowski K; Wypych A; Ostaszewski R
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684570
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-based peptidomimetics targeting neuropilin-1: Synthesis, molecular docking study and in vitro biological activities.
Richard M; Chateau A; Jelsch C; Didierjean C; Manival X; Charron C; Maigret B; Barberi-Heyob M; Chapleur Y; Boura C; Pellegrini-Moïse N
Bioorg Med Chem; 2016 Nov; 24(21):5315-5325. PubMed ID: 27622745
[TBL] [Abstract][Full Text] [Related]
13. Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin.
Lior Y; Shtriker E; Kahremany S; Lewis EC; Gruzman A
Eur J Med Chem; 2022 Jan; 228():113969. PubMed ID: 34763945
[TBL] [Abstract][Full Text] [Related]
14. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
[TBL] [Abstract][Full Text] [Related]
15. One-pot synthesis and sigma receptor binding studies of novel spirocyclic-2,6-diketopiperazine derivatives.
Ghandi M; Sherafat F; Sadeghzadeh M; Alirezapour B
Bioorg Med Chem Lett; 2016 Jun; 26(11):2676-9. PubMed ID: 27090556
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity evaluation of the cyclic dipeptides arylidene N-alkoxydiketopiperazines.
Tian X; Feng J; Fan SM; Zhen XL; Han JR; Liu SX
Bioorg Med Chem; 2016 Nov; 24(21):5197-5205. PubMed ID: 27594550
[TBL] [Abstract][Full Text] [Related]
17. Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure.
Ding Z; Ma M; Zhong C; Wang S; Fu Z; Hou Y; Liu Y; Zhong L; Chu Y; Li F; Song C; Wang Y; Yang J; Li W
Bioorg Med Chem; 2020 Jan; 28(1):115186. PubMed ID: 31759826
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial and antitumor activity of peptidomimetics synthesized from amino acids.
Li H; Fu S; Wang Y; Yuan X; Liu L; Dong H; Wang Q; Zhang Z
Bioorg Chem; 2021 Jan; 106():104506. PubMed ID: 33276980
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
Gong G; Qi J; Lv Y; Dong S; Cao C; Li D; Zhao R; Li Z; Chen X
Chem Pharm Bull (Tokyo); 2020; 68(5):466-472. PubMed ID: 32378544
[TBL] [Abstract][Full Text] [Related]
20. Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt.
Kim YB; Kang CW; Ranatunga S; Yang H; Sebti SM; Del Valle JR
Bioorg Med Chem Lett; 2014 Oct; 24(19):4650-4653. PubMed ID: 25205195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
